Nettoinventarwert (NAV)
| 638.24 USD | -0.71 USD | -0.11 % |
|---|
| Vortag | 638.95 USD | Datum | 22.10.2026 |
HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund A Cap USD Fonds Kurs - 1 Jahr
Fundamentaldaten
| Valor | 35003342 |
| ISIN | LU1540961759 |
| Name | HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund A Cap USD Fonds |
| Fondsgesellschaft | HBM Partners |
| Aufgelegt in | Luxembourg |
| Auflagedatum | 30.12.2011 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 14’778’446.22 |
| Depotbank | Pictet & Cie (Europe) S.A. (Luxembourg) |
| Zahlstelle | FundPartner Solutions (Europe) S.A. |
| Fondsmanager | Ivo Staijen |
| Geschäftsjahresende | 31.12. |
| Berichtsstand | 20.10.2026 |
Anlagepolitik
So investiert der HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund A Cap USD Fonds: The investment objective of the Sub-Fund is to achieve long-term capital growth. The goal is to generate a value trend that exceeds the performance of the NASDAQ Biotechnology Index (the “Benchmark”). No guarantee can be given that the investment objective will be achieved.